Source: Annual Congress 2005 - Respiratory infections and inflammations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Audet, P. Carignan, C. Girard, M. F. Otis (Maria, Canada). High prevalence of yeasts and mycosis infections in a COPD population after long term use of inhaled steroid. Eur Respir J 2005; 26: Suppl. 49, 2600

Member's Comments

No comment yet.

Related content which might interest you: Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 The risk of mycobacterial infections associated with inhaled corticosteroid use Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017 Year: 2017 Prevalence of oral corticosteroid use in the German severe asthma population Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019 Year: 2019 Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Effect of inhaled steroids on long term prognosis of lung function in adults with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 664s Year: 2004 Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Are inhaled corticosteroids increasing the “load” for some patients with COPD? Source: Eur Respir J, 50 (4) 1701848; 10.1183/13993003.01848-2017 Year: 2017 Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Source: Eur Respir J 2010; 36: 751-757 Year: 2010 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? Source: Eur Respir J 2011; 37: 1-3 Year: 2011 Barriers to adherence to inhaled corticosteroids in a high adherent population of children with asthma Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Source: Eur Respir J 2009; 34: 641 Year: 2009 Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use Source: Eur Respir J, 57 (5) 2003388; 10.1183/13993003.03388-2020 Year: 2021 Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children. Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017